Ads
related to: t-cell therapy- How This Treatment Works
Get Info On Lymphoma
Treatment & See How It Works
- Safety & Side Effects
Read Important Safety And Possible
Side Effects Information.
- Treatment Centers
Find A Treatment Center Near You
FDA-Approved Treatment Option
- Take The Quiz
Find Out If This Treatment Option
Is Right For You
- Care Partner Support
Find Out More About
Lymphoma Treatment Options
- Real Patient Stories
Hear How Cell Therapy Could Help
From Real Patients And Caregivers
- How This Treatment Works
Search results
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe CD19-directed chimeric antigen receptor (CAR) T cell therapy is indicated for MCL patients who...
Why Is Bristol Myers Squibb Stock Trading Higher On Friday? - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 4 days agoOn Thursday, the FDA approved Bristol Myers Squibb Co’s BMY Breyanzi (lisocabtagene maraleucel;...
Circadian checkpoint - Nature Immunology
Nature· 1 day agoImmune cell function and responses to immune checkpoint blockade are affected by the time of day owing to circadian rhythms. Data now published in Cell examine the effects of circadian biology ...
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma - Blood...
Nature· 4 days agoIn this retrospective, single-center analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor T-cell therapy ...
ASCO: Novel CAR T therapy and shorter targeted the | Newswise
Newswise· 4 days agoThe novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy obecabtagene autoleucel (obe-cel) achieved durable remissions ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoSÖDERTÄLJE, Sweden and SAN FRANCISCO and KYOTO, Japan, May 30, 2024 (GLOBE NEWSWIRE) -- Anocca AB (Anocca), a leading T-cell receptor-engineered
ASCO24: Tagrisso in the spotlight, Caribou’s adjustment and Lilly’s KRAS competitor
BioPharma Dive via Yahoo Finance· 18 hours agoAstraZeneca’s targeted therapy could see wider use after ASCO data. Elsewhere, Caribou sought to...
Piper Sandler maintains target on Iovance shares, reiterates overweight By Investing.com
Investing.com· 17 hours agoThe firm's stance comes in the wake of discussions at the recent ASCO meeting with a key opinion...
Biotech faces a reckoning: 'We've lost our luster in cell therapies'
FierceBiotech· 6 days agoThis story is part one in a four-part series about cell therapy created by the Fierce Biotech team....
Despite recent struggles, local industry leaders say biotech will bounce back — with a little help -...
The Business Journals· 6 days ago“I think now it should be ‘eds and new meds’ with this evolution here in [cell and gene therapy]...
Ads
related to: t-cell therapy
